Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl

Add To Compare

previously known as Nippon India Pharma Dir DR until

NAV on May 17, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 7,133 cr
Turnover Ratio 18.67%
Expense Ratio 0.92%
Exit Load 1.00%if redeemed within
1 Months
0.00%if redeemed after 1 Months
Returns
  • 1M: 2.55%
  • 1Y: 54.25%
  • 3M: -0.08%
  • 3Y: 17.11%
  • 6M: 18.10%
  • 5Y: 28.43%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since about 19 years) Kinjal Desai (Since almost 6 years)
ISIN INF204K01I43
Fund Family Nippon India
P/E Ratio 40.47
P/B Ratio 6.24
Launch Date January 01, 2013
Benchmark S&P BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs S&P BSE Healthcare TR INR

Alpha 2.85
Beta 0.93
R-Squared 95.34
Info Ratio 0.78
Tracking Err 3.29
Sortino 1.460
Sharpe 0.849
Std Dev 14.420
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet

-
Best Arbitrage Fund Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
14.042 279 cr 0.68% -
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
32.860 58.21% 3,835 cr 1.04% -
29.094 55.80% 894 cr 0.83% -
478.689 54.89% 7,133 cr 0.92% -
393.163 53.19% 2,667 cr 0.95% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon India